Higher seroprevalence of hepatitis E virus in autoimmune hepatitis: Role of false-positive antibodies.

Cirrhosis Hampers Early and Rapid Normalization of Natural Killer Cell Phenotype and Function in Hepatitis C Patients Undergoing Interferon-Free Therapy.

Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.

Impact of sustained virological response with DAAs on gastroesophageal varices and Baveno criteria in HCV-cirrhotic patients.

Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation.

Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.

Curb land grabbing to save the Amazon.

Contributing awareness of autoimmune hepatitis in HIV patients.

Effectiveness, safety/tolerability of OBV/PTV/r Âą DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

Quality of life in patients with hepatitis C. Importance of treatment.

Simplified follow-up of patients with mild chronic hepatitis C in areas with limited access to antiviral therapy.

Characterization and study of the antibacterial mechanisms of silver nanoparticles prepared with microalgal exopolysaccharides.

Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis.

Elimination of hepatitis C virus infection from a hemodialysis unit and impact of treatment on the control of anemia.

Hepatitis C virus early kinetics and resistance-associated substitution dynamics during antiviral therapy with direct-acting antivirals.